Ctrl K
US Stock Screener
Filter 5,800+ US stocks across valuation, growth, quality, income, and momentum metrics.
US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | $1130.73 | 0.6% | $1.06T | 49.3 | 94.8% | 0.5% | Healthcare | 52.2% | 49.6% | ||
| 2 | Johnson & Johnson | $268.53 | -0.2% | $646.41B | 24.3 | -15.3% | 1.9% | Healthcare | 51.1% | 7.7% | ||
| 3 | AbbVie Inc. | $248.00 | -0.3% | $438.16B | 104.6 | 68.1% | 2.6% | Healthcare | 18.6% | 10.4% | ||
| 4 | Merck & Co., Inc. | $148.19 | -0.2% | $366B | 20.4 | -80.7% | 2.2% | Healthcare | 76.6% | 4.2% | ||
| 5 | UnitedHealth Group Incorporated | $402.08 | 0.3% | $365.15B | 30.4 | -32.6% | 2.2% | Healthcare | 25.2% | 6.5% | ||
| 6 | Novartis AG | $138.26 | 0.4% | $262.79B | 19.2 | -3.4% | 2.9% | Healthcare | 7% | 0.8% | ||
| 7 | Thermo Fisher Scientific Inc. | $600.07 | -0.5% | $223B | 33.8 | 7.6% | 0.3% | Healthcare | 23.7% | 7.2% | ||
| 8 | Amgen Inc. | $390.99 | -0.6% | $211.02B | 27.5 | 31.6% | 2.4% | Healthcare | 40.3% | 9.2% | ||
| 9 | Novo Nordisk A/S | $45.03 | -0.3% | $199.96B | 12.6 | 5% | 4% | Healthcare | -16.8% | 5.6% | ||
| 10 | Abbott Laboratories | $104.93 | -0.6% | $182.77B | 28.2 | -53.4% | 2.2% | Healthcare | -20.2% | 6.6% | ||
| 11 | Gilead Sciences, Inc. | $145.64 | -0.7% | $180.82B | 21.5 | -153.2% | 2.2% | Healthcare | 26.5% | 5.5% | ||
| 12 | Pfizer Inc. | $27.65 | -0.5% | $157.56B | 20.3 | -59.9% | 6.2% | Healthcare | 13.2% | -0.2% | ||
| 13 | Danaher Corporation | $203.41 | -0.9% | $142.99B | 40.4 | 19.8% | 0.6% | Healthcare | 3.3% | 4.6% | ||
| 14 | Vertex Pharmaceuticals Incorporated | $522.02 | -1.3% | $132.49B | 34.1 | 22.8% | — | Healthcare | 33.8% | 10.6% | ||
| 15 | Bristol-Myers Squibb Company | $64.49 | -0.3% | $131.69B | 18.7 | 83.4% | 3.8% | Healthcare | 38.5% | 3.1% | ||
| 16 | Intuitive Surgical, Inc. | $352.99 | 0.8% | $124.7B | 44.9 | 22.6% | — | Healthcare | -25.5% | 20.7% | ||
| 17 | CVS Health Corp. | $96.34 | 0.3% | $122.92B | 69.3 | 5.6% | 2.8% | Healthcare | 36.7% | 7.4% | ||
| 18 | AstraZeneca PLC | $158.00 | -1.3% | $122.45B | 12.1 | -22% | 4% | Healthcare | -1.9% | 8.6% | ||
| 19 | Medtronic plc | $91.90 | -0.5% | $117.99B | 24.6 | 11.8% | 3.1% | Healthcare | -0.6% | 9.8% | ||
| 20 | McKesson Corporation | $889.46 | 0% | $106.02B | 23.2 | 49.1% | 0.3% | Healthcare | 27.6% | 8.8% | ||
| 21 | Stryker Corporation | $274.57 | -0.7% | $105.26B | 32.7 | 27.8% | 1.2% | Healthcare | -29.7% | 8.5% | ||
| 22 | Sanofi | $43.04 | -0.3% | $103.35B | 11.6 | -84.5% | 6% | Healthcare | -7.8% | 21.2% | ||
| 23 | GSK plc | $48.81 | 0.6% | $97.79B | 13.0 | -10.9% | 3.4% | Healthcare | 21.2% | 3.2% | ||
| 24 | Elevance Health Inc. | $409.40 | 1.9% | $88.79B | 16.3 | -4.3% | 1.7% | Healthcare | 30.4% | 6.3% | ||
| 25 | HCA Healthcare, Inc. | $399.32 | -0.7% | $86.45B | 14.1 | 25.5% | 0.7% | Healthcare | -3.8% | 7.3% | ||
| 26 | Regeneron Pharmaceuticals, Inc. | $803.15 | -0.9% | $82.74B | 19.4 | 1.9% | 0.4% | Healthcare | 45.1% | 9.3% | ||
| 27 | Cigna Corporation | $281.06 | 1.9% | $74.35B | 12.7 | 31.9% | 2.2% | Healthcare | -8.3% | 7.7% | ||
| 28 | Boston Scientific Corporation | $45.45 | 1% | $67.55B | 23.4 | 46.7% | — | Healthcare | -58.4% | 13.5% | ||
| 29 | argenx SE | $990.87 | -1.6% | $63.82B | 50.5 | 446.7% | — | Healthcare | 31.1% | 234.9% | ||
| 30 | Cencora, Inc. | $324.77 | 0% | $63.19B | 40.8 | 38.5% | 0.7% | Healthcare | 9% | 5.1% | ||
| 31 | Takeda Pharmaceutical Company Limited | $18.25 | -0.4% | $58.04B | 43.9 | 32.7% | 3.7% | Healthcare | 20% | 4% | ||
| 32 | Cardinal Health, Inc. | $241.25 | 0.3% | $56.5B | 33.4 | 12.1% | 0.9% | Healthcare | 60% | 14.2% | ||
| 33 | Moderna, Inc. | $138.74 | -1.1% | $55.05B | -19.1 | -6% | — | Healthcare | 465.2% | -27.2% | ||
| 34 | Humana Inc. | $418.00 | 3.7% | $50.19B | 42.5 | -19% | 0.9% | Healthcare | 29.9% | 18.3% | ||
| 35 | Edwards Lifesciences Corporation | $85.93 | -0.9% | $49.48B | 47.0 | -75% | — | Healthcare | 8.1% | 14.6% | ||
| 36 | Becton, Dickinson and Company | $177.22 | -1.1% | $48.83B | 30.4 | -40.3% | 2.4% | Healthcare | 51.3% | -2.6% | ||
| 37 | Natera, Inc. | $324.15 | 0% | $46.42B | -213.3 | 28.8% | — | Healthcare | 93.6% | 37.8% | ||
| 38 | Teva Pharmaceutical Industries Limited | $37.09 | 0.9% | $43.8B | 30.9 | 475% | — | Healthcare | 90.5% | 4.1% | ||
| 39 | Revolution Medicines, Inc. | $205.72 | -0.8% | $43.74B | -34.6 | -96.5% | — | Healthcare | 404.9% | — | ||
| 40 | Veeva Systems Inc. | $263.14 | -0.6% | $42.75B | 48.4 | 25.1% | — | Healthcare | -6.3% | 16.5% | ||
Showing 40 of 1,129 stocks